Genomics References






CART Multiplexed Quantification of CAR-T Subtypes by PCR   AAPS:NBC
MDS Assessing Clonal Evolution of Myeloid Neoplasms by Flow Cytometry Guided, Cell-Enriched Next Generation Sequencing   AACR 2023
CAR-T A Universal Approach for Generation of Robust CAR-agnostic Calibrators for qPCR Quantification   WIRB 
N/A Modular ddPCR assay design for highly sensitive single nucleotide variant detection   AACR
heme Monitoring of Tisagenlecleucel Transgene DNA Using a Quantitative Polymerase Chain Reaction Assay Molecular Therapy Methods & Clinical Development  
Pan tumor Optimizing reference mixture samples for bioinformatics pipeline assessment on variant calling detection for cancer diagnostics and treatment   AMP
AML (heme) Evaluating machine learning methods for accurate variant calling detection on acute myeloid mutation analysis   AMP
Pan tumor Noise reduction using a positional variant-dependent error model for the detection of low frequency variants in a pan-cancer next-generation sequencing panel   AMP
Solid tumor Detection of Low-Frequency Variants in Minimal Residual Disease (MRD) Monitoring of Acute Myeloid Leukemias   AMP
Melanoma Effects of melanin on NanoString gene and miRNA expression assays for utilization in biomarker analysis for melanoma   AACR
Pan tumor Multi-omic single cell sequencing for deep cell immune profiling and identification of potential biomarkers for cell therapy and immunotherapy   AACR
Solid Tumor Accelerating Oncology Drug Development by Patient Stratification   World Pharma Week 
Melanoma Adjuvant dabrafenib plus trametinib versus placebo in patients with resected, BRAFV600-mutant, stage III melanoma (COMBI-AD): exploratory biomarker analyses from a randomised, phase 3 trial Lancet Oncology  
Pan Tumor SABPA Chair - SABPA Frontiers in Therapeutics and Diagnostics (FTD)   SABPA Frontiers in Therapeutics and Diagnostics (FTD) Forum 
Breast Development and Characterization of PTEN IHC Assay for Testing Breast Cancer Patients Specimens    SABCS
AML FLT3 inhibitors added to induction therapy induce deeper remissions  Blood  
AML Identification of Low-Frequency Variants in AML Populations    AMP
Solid Tumor Evaluation of Illumina TSO500 Performance in Clinically Significant Sample Types and Input Levels    AMP
Breast Biomarker Selection of Cancer Patients for treatment with FGFR TKI   AMP
Heme Enabling oncology drug approval by successful development of companion diagnostics   Biomarkers and Precision Medicine Conference
AML FLT3-Explorer: A Bioinformatics Pipeline for Detecting Low Signal in FLT3 Internal Tandem Duplications in Acute Myeloid Leukemia   AACR
Breast “Fit-for-Purpose” PIK3CA Assays for Patient Stratification in Breast Cancer Clinical Trials   AACR
Heme/Solid Characterization of T Cell Clonality and Tumor Mutation Burden Utilizing the TCRSeq NGS and the Comprehensive NGS Assays   AACR
heme  Comparison of commercially available myeloid next-generation sequencing assays   AACR
AML Development of a Novel Next-Generation Sequencing (NGS)-Based Assay for Measurable Residual Disease (MRD) in FLT3-ITD Acute Myeloid Leukemia (AML) and Its Potential Clinical Application in Patients   AACR
Solid Progress toward non-invasive oncology diagnostics: Evaluation of cfDNA next-generation sequencing assays   AACR
AML Development of a Novel Next-Generation Sequencing (NGS)-Based Assay for Measurable Residual Disease (MRD) in FLT3-ITD AML and Its Potential Clinical Application in Patients Treated With Chemotherapy Plus FLT3 Inhibitors.    ASH
Multi Assessment of Pre-Analytical Effects on RNA Sequencing   AMP
NSCLC Optimization of testing methods in detecting MET amplification, expression, and activation for targeted MET TKI treatment in non-small cell lung cancer patients   AMP
Multi Automated Analysis of Melanoma Gene Expression Patterns by Sequential Interrogation of Variable RNA Average Count-space.   AAPS
  Applications of NanoString Technology in Clinical Trials   ASHG
Multi Nano-PipeRNA: A Modular Tool for Analysis of Complex NanoString Datasets   ISCB
AML Concordance between Bone Marrow and Peripheral Blood Samples for Assessment of FLT3 Internal Tandem Duplication (ITD) Mutations: Data from Patients Screened for Participation in Quantum-R, a Global, Randomized, Open-Label, Phase 3 Study Examining the Effect of Quizartinib Monotherapy Vs Salvage Chemotherapy on Overall Survival in Patients with FLT3- ITD - Mutated AML Who Are Refractory to or Have Relapsed after First-Line Therapy   ASH
Heme & Solid qPCR Methods for Characterizing Cellular Kinetics   AAPS
Heme & Solid Transforming Oncology Drug Clinical Development by Next Generation Sequencing Testing   International Precision Medicine Convention
Heme & Solid Transforming Oncology Drug Clinical Development by Next Generation Sequencing Testing   AAPS
  Analytical Evaluation and Applications of the nCounter Vantage™ RNA:Protein Immune Cell Profiling Panel   AMP
  Next Generation Sequencing (NGS) Evaluation of CYP11B1 and CYP11B2 Single Nucleotide Variants (SNP) for a Correlation in Hypertension and Cushing Syndrome   ASHG
  Development of Bioassays for Checkpoint Immunotherapy.    LSCO
  Biomarkers to Support the Development and Clinical Application of Immunotherapy Combinations   LSCO
  Liquid Biopsy:  Non-Invasive Tumor Diagnosis and Treatment Monitoring   SABPA-MDD
  Promises and Challenges of Using Digital PCR   LSCO
  Copy Number Variations:  Digital PCR, Nanostring, and Next Generation Sequencing.     Digital PCR Conference
  Digital PCR for Patient Monitoring and Stratification in Clinical Trials.     Tri-Con
  Nanostring Assays for Patient Monitoring and Stratification in Clinical Trials. 
  Development of a nanostring copy number assay for a customized 55 gene panel using challenging formalin-fixed paraffin-embedded (FFPE) tumor samples.    AACR